DECREASED POLYGLUTAMYLATION OF METHOTREXATE IN ACUTE LYMPHOBLASTIC-LEUKEMIA BLASTS IN ADULTS COMPARED TO CHILDREN WITH THIS DISEASE

被引:0
|
作者
GOKER, E
LIN, JT
TRIPPETT, T
ELISSEYEFF, Y
TONG, WP
NIEDZWIECKI, D
TAN, C
STEINHERZ, P
SCHWEITZER, BI
BERTINO, JR
机构
[1] MEM SLOAN KETTERING CANC CTR,DEPT MOLEC PHARMACOL,NEW YORK,NY 10021
[2] MEM SLOAN KETTERING CANC CTR,DEPT MED,NEW YORK,NY 10021
[3] MEM SLOAN KETTERING CANC CTR,DEPT PEDIAT,NEW YORK,NY 10021
[4] MEM SLOAN KETTERING CANC CTR,DEPT BIOSTAT,NEW YORK,NY 10021
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We compared blast cells from adult and pediatric patients with untreated acute lymphoblastic leukemia (ALL) (as separated groups of T-lineage cell and B-lineage cell ALL) to determine if methotrexate (MTX) polyglutamate formation in adult patients might be a contributing cause to the known difference in clinical outcome, since MTX is a key drug in chemotherapy regimens. Adult B-lineage cell ALL blasts and blasts from the patients with T-lineage cell ALL accumulated lower amounts of total MTX and polyglutamates, especially long-chain MTX polyglutamates (glu3-6) than pediatric B-lineage cell ALL blasts. In view of the importance of polyglutamylation of MTX as a determinant of cytotoxicity of this drug, decreased formation of MTX polyglutamates is likely a contributing cause to the lower cure rate in adult ALL and T-lineage cell ALL as compared to childhood B-lineage cell ALL.
引用
收藏
页码:1000 / 1004
页数:5
相关论文
共 50 条
  • [41] INTERMEDIATE DOSE METHOTREXATE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA RESULTING IN DECREASED INCIDENCE OF TESTICULAR RELAPSE
    BRECHER, ML
    WEINBERG, V
    BOYETT, JM
    SINKS, LF
    JONES, B
    GLICKSMAN, A
    HOLLAND, JF
    FREEMAN, AI
    CANCER, 1986, 58 (05) : 1024 - 1028
  • [42] MONITORING OF MINIMAL RESIDUAL DISEASE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    LINDERKAMP, C
    BEYERMANN, B
    BAUMGARTEN, E
    HANEL, C
    SEEGER, K
    SCHMID, H
    ZINGSEM, J
    HENZE, G
    BLOOD, 1993, 82 (10) : A543 - A543
  • [43] COMPARISON OF CHEMOTHERAPY WITH IMMUNOTHERAPY FOR MAINTENANCE OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN AND ADULTS
    STRYCKMANS, PA
    OTTEN, J
    DELBEKE, MJ
    SUCIU, S
    FIERE, D
    BURY, J
    SOLBU, G
    BENOIT, Y
    BLOOD, 1983, 62 (03) : 606 - 615
  • [44] CYTOGENETIC STUDY IN 22 ADULTS AND 3 CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    ARANATREJO, RM
    CERVANTESPEREDO, A
    ROZEN, E
    KASSACK, JJ
    GUTIERREZ, M
    KOFMANALFARO, S
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1993, 45 (01): : 43 - 48
  • [45] TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHINESE ADULTS
    CHENG, PNM
    TSO, SC
    LEUKEMIA RESEARCH, 1986, 10 (01) : 112 - 112
  • [46] NEUROLOGIC COMPLICATIONS OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
    CASCINO, TL
    POSNER, JB
    NEUROLOGY, 1981, 31 (04) : 43 - 43
  • [47] THERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS (ALL)
    GOKBUGET, N
    HOELZER, D
    ONKOLOGIE, 1995, 18 (04): : 292 - 300
  • [48] PROGRAMMED THERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA OF ADULTS
    ISAEV, VG
    SAVCHENKO, VG
    KUCHER, RA
    ABAKUMOV, YM
    PAROVICHNIKOVA, YN
    TERAPEVTICHESKII ARKHIV, 1992, 64 (08): : 82 - 87
  • [49] IMMUNOLOGICAL ANALYSIS OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
    KITA, K
    NASU, K
    KAMESAKI, H
    DOI, S
    TEZUKA, H
    TAKIUCHI, Y
    TATSUMI, E
    FUKUHARA, S
    NISHIKORI, M
    UCHINO, H
    SHIRAKAWA, S
    ACTA HAEMATOLOGICA JAPONICA, 1984, 47 (05): : 1115 - 1127
  • [50] THE BIOLOGY AND TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
    COPELAN, EA
    MCGUIRE, EA
    BLOOD, 1995, 85 (05) : 1151 - 1168